Clinical trial
Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma
NCT00003388 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00003388 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma |
| Official title | A Phase II Study of Doxil (Liposomal Doxorubicin), Cyclophosphamide, Vincristine and Prednisone for AIDS-Related Systemic Lymphoma |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Biological, Drug, Radiation |
| Interventions | filgrastim, cyclophosphamide, cytarabine, methotrexate, pegylated liposomal doxorubicin hydrochloride, prednisone, vincristine sulfate, radiation therapy |
| Enrollment | 38 |
| Start date | Jul 26, 1999 |
| Primary completion | Apr 1, 2003 |
| First posted | Dec 2, 2003 |
| Last update posted | Jun 22, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: